Sort
172,184 grants matching “inflammation”
Development of mRNA-platform vaccines
$812,208Fredrick Heath Damron · West Virginia University · R01 · FY2024 · AI
DNA Repair Capacity Assays for Lung Disease Risk Assessment
$812,106Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · U01 · FY2019 · CA
Impact of the Intestinal Microbiome on HIV/SIV Vaccines
$812,077Herbert W Virgin · Washington University · R01 · FY2017 · OD
Improving Outcomes Assessment in Chronic Graft versus Host Disease
$812,043Stephanie J Lee · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$811,997Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
URSODIOL-METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS
$811,957University Of Texas Sw Med Ctr/Dallas · R01 · FY2002 · DK
Childhood Adversity and Cardiovascular Health among Puerto Rican Youth
$811,890Shakira Franco Suglia · Columbia University Health Sciences · R01 · FY2015 · HL
Effect of Dietary Carbohydrate on Diabetes Control and Beta Cell Function in Children with Newly Diagnosed Diabetes.â
$811,825Belinda S Lennerz · Boston Children'S Hospital · R01 · FY2023 · DK
Role of Adaptive Immunity in Etiology of Alzheimerâs Disease andAlzheimerâs Disease-Related Dementias
$811,823Douglas C Wallace · Children'S Hosp Of Philadelphia · R01 · FY2025 · AG
Immuno-Genetic Epidemiology of Complex Malaria in India
$811,765Jane Carlton · New York University · U19 · FY2014 · AI
Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies
$811,718David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Risk stratification in pulmonary arterial hypertension: Intersection of OMICs and longitudinal phenotypes through the PAH Biobank
$811,691William C Nichols · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · HL
Claude D. Pepper Older Americans Independence Center (OAIC)
$811,688Marco Pahor · University Of Florida · P30 · FY2011 · AG
Establishment and Validation of a Novel Animal Model of Fibromyalgia
$811,652Jianren Mao · Massachusetts General Hospital · R33 · FY2025 · NS
HLD-mediated cholesterol efflux and plaque inflammation in MESA
$811,635Steven J Shea · Columbia University Health Sciences · R01 · FY2017 · HL
REGULATION OF NF-KAPPA B
$811,614Inder Mohan Verma · Salk Institute For Biological Studies · R37 · FY2008 · AI
Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approaches
$811,605Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · AG
DORMIR: Determinants, Outcomes, Responses and Markers of Insufficient sleep in Rural-Urban settings
$811,585Azizi Seixas · University Of Miami School Of Medicine · R01 · FY2022 · HL
Forward Genetic Analysis of Innate Immune Signaling
$811,539Bruce A Beutler · Scripps Research Institute, The · U19 · FY2014 · AI
Quantitative Proteomics to Develop Robust Senescence-Related Biomarkers for Aging
$811,526Birgit Schilling · Buck Institute For Research On Aging · U01 · FY2020 · AG
Integrated analysis of CVD risk in HIV: gut microbiota, immune function and metabolites
$811,490Qibin Qi · Albert Einstein College Of Medicine · R01 · FY2019 · HL
Gating mechanisms and pharmacology of P2X receptor channels
$811,445Kenton Swartz · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
Research Training in Respiratory Biology
$811,434Julian Solway · University Of Chicago · T32 · FY2006 · HL
Design And Development Of Experimental Therapeutics
$811,428Nigel H. Greig · National Institute On Aging · ZIA · FY2019 · AG
Optimization of CXCR1/2 antagonist SX-576 for the treatment of BPD and COPD
$811,424Dean Yoshimasa Maeda · Syntrix Biosystems, Inc. · R44 · FY2011 · HL